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ABSTRAK 
Objektif: Tujuan kajian ini dijalankan adalah untuk melihat perbezaan keanjalan salur 
darah arteri yang signifikan diantara penghidap diabetes dan tanpa diabetes melalui 
pengukuran indeks augmentasi dan juga melihat kesan diantara dua kumpulan ubat 
anti-diabetik, (monoterapi sulfonylurea dan kombinasi sulfonylurea dengan 
metformin) terhadap keanjalan salur darah arteri. 
Metodologi: Ini adalah kajian kes-kontrol yang dijalankan di klinik rawatan keluarga 
dan klinik diabetik, HUSM daripada May 2004 hingga May 2005. Seramai seratus dua 
subjek pengidap diabetes dan 102 subjek tanpa diabetes yang berpadanan umur dan 
jantina telah dipilih selepas penerangan mengenai protocol kajian dan mendapat 
kebenaran secara verbal. Indeks augmentasi diukur dengan menggunakan alat 
"Sphygmocor® " dan segala pengukuran dilakukan oleh penyelidik selepas kajian 
validasi. Bacaan indeks augmentasi ini kemudiannya dianalisa. 
Kcputusan: Purata indeks augmentasi bagi pengidap diabetes adalah lebih tinggi dan 
signifikan daripada subjek tanpa diabetes ( 140.32 ± 12.0% V s 128.77 ± 1 0.69°/o, P < 
O.OOOI ). Walau bagaimanapun, tiada perbezaan indeks augmentasi yang signifikan 
diantara dua kumpulan anti-diabetik, monoterapi sulfonylurea dan kombinasi 
sulfonylurea dengan metformin(140.51 ± 11.42 Vs 140.14 ± 12.86, 95% CI: -4.40. 
5.15, p = 0.877). 
Xll 
Kesimpulan: Pesakit diabetes mempunyai salur darah arteri yang kurang anjal 
berbanding dengan subjek tanpa diabetes yang berpadanan umur dan jantina, ini 
menerangkan menerangkan mengapa diabetes mellitus berkaitan dengan peningkatan 
risiko kardiovaskular. Kajian ini juga menunjukkan bahawa dua kumpulan anti-
diabetik tidak mempunyai kesan yang berbeza keatas keanjalan salur darah arteri. 
Xlll 
ABSTRACT 
A STUDY ON THE EFFECT OF ORAL HYPOGL YCAEMIC AGENTS ON 
ARTERIAL STIFFNESS IN MALAY PATIENTS WITH TYPE 2 DIABETES 
MELLITUS. 
Objective : The purpose of this study is to see whether there was any significant 
difference in arterial stiffness (as measured by augmentation index) between diabetic 
and non diabetic subjects and to see whether there was any significant difference 
between two different oral hypoglycaemic agents(OHA) regimens, (sulphonylurea 
monotherapy and metformin in combination with sulphonylurea therapy) on arterial 
stiffness. 
Methods : This was a case control study conducted in the Klinik rawatan 
keluarga(KRK) and Diabetic clinic, HUSM from May 2004 till May 2005. Hundred 
and two diabetic subjects and hundred and two age- and sex-matched non-diabetic 
control subjects were recruited after obtaining verbal consent following explanation of 
study protocol. Augmentation index (AI) was measured using the Sphygmocor 
apparatus and all measurements were performed by the researcher after an earlier 
validation study. These mean augmentation index measurements were then analyzed. 
Result : The mean of AI of diabetic subjects was significantly higher than non 
diabetic subjects ( 140.32 ± 12.0% Vs 128.77 ± 10.69%, P < 0.0001 ). However, there 
XlV 
was no significant difference in mean AI between two different OHA regimen groups 
in diabetic subjects (140.51 ± 11.42 Vs 140.14 ± 12.86, 95% CI: -4.40, 5.15, p = 
0.877). 
Conclusion: Diabetic patients have increased arterial stiffness compared with age- and 
sex-matched non diabetic subjects, which may partly explain why diabetes mellitus 
are associated with increased cardiovascular risk. This study also showed that two 
different groups of oral hypoglycaemic agents have no effect in relation to arterial 
stiffness. 
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CHAPTER ONE: INTRODUCTION 
Insulin resistance and type 2 Diabetes are major causes of morbidity and mortality in 
the industrialized world. It has been estimated that the prevalence of type 2 diabetes 
mellitus will increase from the present 160 million to 215 million in 2010 (Amos et 
a/., 1997). Type 2 diabetes mellitus increases the risk of cardiovascular disease 2 to 4 
fold as compared to non-diabetic subjects (Kannel WB and McGee DL, 1987). Of the 
patients diagnosed with myocardial infarction about 20% have previously known type 
2 diabetes ( Tenerz et a!., 2001 ). 
In Malaysia, from the second national Health and Morbidity Survey 1996, the 
prevalence of diabetes in Malaysia was found to be 8.2%, and about 10% suffered of 
stroke and cardiovascular diseases associated with their diabetic condition. Their 
survey also reported that the prevalence of diabetes is higher in Indians (11.5%) 
compared to other races. However, they found no significant difference in gender. 
The most common cause of disability and death among subjects with non-insulin 
dependent diabetes mellitus (NIDDM) is macro vascular disease. In the United States, 
11% of diabetic men and 6% of diabetic women 45 to 64 years of age reported having 
had a heart attack (Barret-Connor E and Orchard T, 1984). These percentages are 2.5 
times higher in men and 4.0 times higher in women than in non-diabetic population. 
Increased risk of atherosclerosis is found even in prediabetic individuals (Haffner SM 
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et a!., 1990), and in populations at high risk of coronary heart disease (CHD), almost 
half of middle-aged men and women with NIDDM have symptomatic CHD at the 
moment their diabetes is diagnosed (Uusitupa M et a!., 1985). These findings indicate 
that atherosclerosis develops gradually during the long latent phase of 
hyperinsulinaemia and glucose intolerance before the actual onset ofNIDDM. 
The reasons and mechanisms for the macro vascular disease in subjects with NIDDM 
are insufficiently known. However, there is evidence that insulin resistance and 
hyperinsulinaemia play an important role (Laakso M et a!., 1991 ). Insulin resistance is 
associated with high triglyceride and low high density lipoprotein (HDL) cholesterol 
concentrations and with an increased tendency to hypertension (Zavaroni J et al., 
1989). In addition to its lipid effects, insulin may have an effect on the thickness and 
structure of the arterial wall. This is shown in the in vitro study that insulin 
concentrations commonly found in humans can cause proliferation of cultured smooth 
muscle cells (Pfeifle B and Ditshuneit A, 1981 ). 
In non-diabetic individuals, increased arterial stiffness is an important cause of 
cardiovascular disease, because arterial stiffness leads to increased systolic pressure 
and ventricular mass and to decreased diastolic coronary perfusion (Westerhof N and 
O'Rourke MF, 1995). There is evidence that metabolic alterations in type 2 diabetes 
and impaired glucose metabolism are associated with increased arterial stiffness. This 
is supported by Atherosclerosis Risk in Communities Study who found that persons 
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with NIDDM or borderline glucose intolerance have stiffer arteries than their 
counterparts with normal glucose tolerance ( Salomaa eta!., 1995). 
In population-based study, they found that Type 2 diabetes mellitus and impaired 
glucose metabolism are associated with decreased total systemic arterial compliance, 
increased aortic augmentation index, and decreased carotid-femoral transit time which 
provides understanding why both type 2 diabetes mellitus and impaired glucose 
metabolism are associated with increased risk for stroke, heart failure and myocardial 
infarction (Schram eta!., 2004). 
The Chennai Urban Population Study also found similar finding where 50 diabetic 
subjects and 50 age and sex matched non-diabetic control subjects found that the mean 
augmentation index of diabetic subjects was significantly higher than non-diabetic 
subjects, which suggest that diabetic patients have increased arterial stiffness 
(Ravikumar et a!., 2002). 
In the Japanese study done by Emoto et a!. (1998) in 60 NIDDM subjects found that 
arterial wall stiffness as measured using ultrasonic phase-locked echo-tracking system 
found that the arterial stiffness were significantly higher in NIDDM subjects than in 
control subjects. The similar finding also found in the study done by Taniwaki eta!. 
(1999) in 271 diabetic patients and 285 healthy age-matched control subjects which 
also demonstrated that aortic pulse wave velocity in Japanese patients with type 2 
diabetes were significantly higher than in age-matched control subjects. The same 
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researcher also found that in the diabetes group, the arterial stiffness were significantly 
higher in the patients with the II genotype than in those with the DD genotype which 
suggest that some genetic factors may be associated with stiffening of the arteries. The 
similar finding also found in the other study. In the Rotterdam study, the 
insertion/deletion (VD) polymorphism of the ACE gene was found to increase 
common carotid stiffness in a cohort study of 3001 adults over aged 54(Mattace-Raso 
eta/., 2004). So, in this study, the researcher focused in the Malay populations. 
As arterial stiffness has become established as a cardiovascular risk factor, it has also 
emerged as a potential target for intervention. Arterial stiffness may become a major 
primary goal of treatment in particular patients at risk of cardiovascular disease. Drugs 
may improve the stiffness of the arterial wall through either functional or structural 
mechanisms (Oliver JJ and Webb DJ, 2003). In a study done by Shimamato H and 
Shimamoto Y in hypertensive patients, 8 weeks of treatment with lisinopril more 
effectively reduced pulse wave velocity than nifedipine (Shimamato H and 
Shimamoto Y, 1995). 
In a study done by Tsuji et a/. (2002) demonstrated that in Otsuka Long-Evans 
Tokushima fatty rats with type 2 diabetes showed an improvement in aortic wall 
distensibility after received 15 weeks of pioglitazone. Satoh et al., (2003) also 
demonstrated that treatment with pioglitazone in patients with type 2 Diabetes mellitus 
for 3 months resulted in a significant decreased in pulse wave velocity (PWV). This is 
in agreement with that of Minamikawa et a/. ( 1998) and Koshiyama et a/. (200 1) who 
4 
reported that intima media thickness (IMT) was significantly reduced 1n type 2 
diabetes patients administered troglitazone or pioglitazone for 3 months. 
However, there is lack of clinical data on the effect of traditional oral hypoglycemic 
agents like metformin or sulfonylurea or combination of both on arterial stiffness in 
patients with type 2 diabetes mellitus although there is a study shown that treatment 
with metformin for 12 weeks improved endothelial function (Kieren et a/., 200 1 ). The 
researcher therefore studied the effect of oral hypoglycemic agent on arterial stiffness 
in type 2 Diabetes mellitus and based on previous studies, this study also took three 
months as a minimum duration of taking oral hypoglycemic agent. In this study, the 
arterial stiffness was assessed by measuring augmentation index (AI) at the radial 
artery. 
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CHAPTER TWO: LITERATURE REVIEW. 
2.1 Overview of arterial stiffness. 
Aortic stiffening is as much an important risk factor in cardiovascular morbidity 
and mortality, as it serves as reliable surrogate marker in clinical endpoints like 
myocardial and cerebrovascular incidents. Elevated aortic stiffness induces high 
systolic blood pressure; augmented pulse pressure with increases ventricular after 
load, reduced subendocardial blood flow and augmented pulsatile stress in the 
peripheral arteries (Breithaupt-Grogler and Belz GG, 1999). 
Arterial stiffness is determined by structural and functional components related to 
the intrinsic elastic properties of the artery. The endothelium, the elastic tissue 
within the intima media layer, and smooth muscle contribute to arterial stiffness 
(Arnett DK eta!., 1994). 
The relationship between arterial stiffness as measured as pulse wave velocity and the 
elastic properties of the arterial wall has been extensively studied (Asmar et al., 1995). 
Despite its non-invasive nature and good sensivity and reproducibility, pulse wave 
velocity was not applied to clinical practice because its recording and calculation were 
difficult and time consuming (Asmar et a!., 1995). However, recent developments of 
non invasive method such as applanation tonometry has open a new era to the clinical 
applications of the analysis of the pulse waveform, amplitude and velocity of the pulse 
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pressure and its also provides a simple, repeatable and sensitive (Wilkinson et a/., 
2002). Radial artery pressure waveforms recorded with tonometry have been shown to 
equal those measured intra-arterially in a large group of normal subjects (Kelly eta/., 
1989). Several studies have now demonstrated that a single generalized transfer 
function can be used to accurately determine central from peripheral pressure in 
normal subjects and in patients with a variety of diseases (Chen et a/., 1997, 
Karamanoglu eta!., 1993,0'Rourke and Gallagher 1996). 
A number of studies have been done to look in the relationship between arterial 
stiffness and cardiovascular disease and its shown that arterial stiffness is 
associated with certain disease such as hypertension, diabetes mellitus, 
hypercholestrolaemia and end-stage renal failure (Glasser et al., 1997). As changes 
can be detected before the appearance of clinically apparent vascular disease, 
arterial stiffness may act either as a marker for the development of future 
atherosclerotic disease, or may be more directly involved in the process of 
atherosclerosis (Mackenzie and Wilkinson, 2002). 
Assessment of the arterial pulse has always been an important part of clinical 
examination, and the changes in the character of the pulse indicated the presence of 
disease. Arterial stiffness may be measured using a variety of different techniques, 
although at present the majority of measurements are made for experimental and 
physiological studies rather than in clinical practice. However, it is likely that over 
the next few year measurement of arterial stiffness will become an increasingly 
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important part of the process of risk assessment, and may possibly also improve the 
monitoring of therapy. 
2.2. Methods of measuring arterial stiffness. 
Measures of arterial stiffness estimate the artery's ability to expand and contract 
with cardiac pulsation and relaxation. Technologic advancements have provided for 
direct, non-invasive visualization of arteries with excellent precision, opening the 
horizon for studies of arterial stiffness in research and clinical practice. While there 
is currently no gold standard, several measures have been used extensively in a 
variety of settings. 
2.2.1. Pulse pressure. 
Pulse pressure is the different between systolic and diastolic blood pressure and is 
recognized since 1922 by Bramwell and Hill ( 1922). Pulse pressure is a valuable 
surrogate marker for arterial stiffness. Both systolic and diastolic blood pressure 
tends to increase with age (Franklin et al., 1997). However, after the age 50-60 
years old, there is no further increase in blood pressure and in some cases it actually 
declines. So, the pulse pressure widens with increasing age. In the Framingham 
cohort diastolic blood pressure was the best predictor of CHD in patients < 50 years 
of age whereas in patients 50-59 years of age systolic and diastolic blood pressure 
as well as pulse pressure predicted CHD comparably (Franklin et al., 2001 ). From 
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60 years of age, pulse pressure was superior to systolic blood pressure in predicting 
CHD (Franklin et a/., 1999). In the Systolic Hypertension in the Elderly Program 
(SHEP) both stroke and total mortality were related to pulse pressure independent 
of mean arterial pressure (Domanski et al., 1999). Not only do ageing and 
hypertension decrease arterial wall elasticity and predispose to CHD, but 
arteriosclerosis also decreases elasticity and increases pulse pressure (Dart and 
Kingwell, 200 1 ). 
Pulse pressure can be measured with standard sphygmomanometer which is one of 
the simplest measure of arterial stiffness and easily practicable in the clinical 
setting. However, pulse pressure alone is inadequate to assess arterial stiffness 
accurately. This is because, measurements of pulse pressure made in the periphery 
which do not always accurately reflect the actual central pulse pressure (Pauca et 
a/., 1992). 
2.2.2. Pulse wave velocity. 
Pulse wave velocity (PWV), the velocity of travel of a pressure wave between two 
arterial sites, can be measured invasively and non-invasively and can be used as an 
index of regional vascular stiffness. The speed at which the pulse wave travels 
through an arterial segment increases with increasing stiffness (Oliver JJ and Webb 
OJ, 2003). Pressure waveforms can be captured by pressure-sensitive transducers 
(Asmar et a/., 1995), Doppler ultrasonography (Sutton-Tyrell et a/., 2001), 
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applanation tonometry (Wilkinson et al., 1998), photopletsymography 
(Loukogeorgakis et al. 2002) or MRI (Mohiaddin et al., 1993). Pulse wave velocity 
can be measured between any arterial segments, but it is usually used to measure 
the wave travel between common carotid and femoral or carotid and radial arteries. 
PWV has been shown to increase with vanous cardiovascular risk factors, 
including age, hypercholestrolemia, type 2 diabetes and hypertension (Oliver JJ and 
Webb DJ, 2003). PWV has also been shown to predict all-cause and cardiovascular 
mortality (Laurent et al., 2001). 
The problem with this technique is some difficulty in estimating the actual arterial 
distance between recording sites by using only surface measurements (Asmar, 
1999). The pulse wave velocity becomes less accurate if the recording points are 
very close together, and therefore, it is limited to use on the larger arteries. 
However, the technique of PWV is valid and reproducible and it is relatively simple 
and can learned fairly easily. The alternative method of measuring PWV is by using 
MRI technique (Mohiaddin et a!., 1993). The advantage of MRI is the accurate 
determination of path length but its use is limited by cost and time. 
2.2.3. Augmentation index (Agl). 
The augmentation index derived from systolic pulse wave analysis. The 
augmentation index is the difference between the first and second systolic peaks 
10 
expressed as a percentage of the pulse pressure, and can be used as a measure of 
arterial stiffness (Mackenzie et al., 2002). It can be measured invasively and non-
invasively from superficial peripheral arteries by using applanation tonometry. 
Applanation tonometry is a sensitive pen like instrument and is used to record 
pressures at the radial or carotid artery, and central blood pressure. The 
augmentation index (Agl) can be calculated from the aortic pressure waveform 
derived using a generalized transfer function. A validated generalized transfer 
function has more than 90% accuracy in generating features of the ascending aortic 
pressure wave (Chen et a!., 1997). The augmentation index (Agl) reflects the 
degree to which central arterial pressure is augmented by wave reflection 
(O'Rourke and Gallagher, 1996). 
In one study 1n 66 patients 1n United States who undergoing diagnostic 
catheterization, augmentation index from carotid artery tonometry derived 
augmentation index with an external micro manometer tipped-probe was compared 
with a micro manometer tipped-catheter and found that there is high correlation 
between the central augmentation index (Agl) and those estimated from non-
invasive carotid tonometry (Chen et al., 1996). 
The augmentation index measured from radial artery also correlates with carotid 
artery intima-media thickness in diabetic and non-diabetic subjects and predicts 
coronary artery disease independent of other risk factors (Ravikumar et al., 2002). 
11 
It also higher in type 2 diabetes subjects compared to non-diabetic subjects 
(Ravikumar et al., 2002). 
So far there is no evidence that the Agl measured from radial artery has prognostic 
value (Oliver JJ and Webb DJ, 2003), but a high carotid Agl has been shown to be 
an independent predictor for ischemic threshold in patients with coronary heart 
disease and of all-cause and cardiovascular mortality in patients with end-stage 
renal failure (London et al., 2001). 
This Pulse Wave Analysis (PW A) system is a simple, non-invasive and validated 
method of measuring arterial stiffness (O'Rourke and Gallagher, 1996). The 
tonometer is the size of a pen, the system is easily portable and, therefore, useful in 
both hospital and clinic settings. This study will use augmentation index measured 
by SphygmoCor machine as index of arterial stiffness. 
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Figure 2.1 Schematic illustration of pulse wave during one cardiac cycle. The 
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Figure 2.2 Examples of pulse waveforms caused by compliant (on the left) 
and shift aortas (on the right) at constant stroke volume. 
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2.2.4. Diastolic pulse contour analysis. 
The diastolic part of the pulse wave can be recorded by applanation tonometry and 
calibrated using a sphygmomanometer (Oliver JJ and Webb DJ, 2003), Information 
can be received from both large artery compliance referred to as C 1 and peripheral 
artery compliance referred to as C2 (Oliver JJ and Webb DJ, 2003). Compliance 
calculated from invasive and non-invasive measurements correlate significantly (Cohn 
et al., 1995). C2 is decreased in hypertensive patients, type 2 diabetes patients, 
postmenopausal women with CHD, and smokers (Cohn et al., 1995). 
The technique does not provide any information on central pressures and 
augmentation index (MacKenzie eta/. 2002). It depends on diastolic component of the 
waveform, which tends to be less reliably recorded than the systolic component 
2.2.5 MRI derived indices 
Magnetic resonance imaging (MRI) technique has been used to measure vascular 
distensibility and compliance. Most of the human studies have been based on 
measurements of the aorta. The aortic distensibility is reduced in hypertensive patients 
(Resnick et al., 1997). Although MRI has the advantage of being non-invasive, it 
remains expensive, and the availability of scanning facilities is limited. 
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2.2.6 Vascular ultrasonography 
The change in the diameter of an artery at a given distending pressure provides a 
measure of arterial stiffness (Oliver JJ and Webb DJ, 2003),). Ultrasound and MRI can 
both be used for measurement of the change in diameter. Mean brachial arterial blood 
pressure can be combined with applanation tonometry at the site of the carotid artery 
to measure carotid pulse pressure more accurately (Oliver JJ and Webb DJ, 2003),). 
The measurement can be made at several different sites such as brachial, radial, and 
femoral arteries or aorta. Reduced aortic distensibility has been associated with 
increased age, CHD, hypertension, hypercholestrolemia and smoking (Stefanadis et 
a/., 2000). It also increased in type 2 diabetic patients (Salooma eta/., 1995). 
2.2. 7 Digital volume pulse 
Photoplethysmography has been used to record the digital volume pulse. This 
technique resembles that of pulse oximetry, and measures the transmission of infrared 
light through the finger, thus detecting changes in flow and producing a volume 
waveform (Chowienczyk et a/., 1999). A problem with this method is that it depends 
on the temperature changes in the peripheral circulation. A study that compared 
photoplethysmography of the digital volume pulse with pulse wave velocity, found 
that pulse wave velocity correlated more closely with the expected influences on 
vascular compliance (Bortolotto et a/., 2000). 
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2.3. Arterial stiffness and vascular risk. 
2.3.1. Age 
Arteries become less elastic by ageing. This is caused by an increase in arterial wall 
thickness secondary to hyperplasia of the intima and by loss of elastin in the media 
and its replacement by collagen (Davies and Struthers, 2003 ). Pulse pressure, a 
surrogate marker of arterial stiffness, increases with age. In the Framingham cohort 
pulse pressure averaged 42 mmHg before the age of 50 years, 50 mmHg between ages 
of 50 and 59 years and increased to 62 mmHg after the age of 60 years (Franklin eta!., 
2001). 
In the Framingham Heart Study offspring cohort in 188 men and 333 women who 
were free of clinical cardiovascular disease, hypertension, diabetes, dyslipidaemia and 
obesity, found that advancing age was the predominant correlate of higher carotid-
femoral pulse wave velocity (Mitchell eta!. 2004). 
Kelly et a!. determined arterial stiffness from the carotid, femoral and radial arteries 
using an applanation tonometer, and analyzed arterial pressure waveforms in 1005 
normal subjects aged 2 to 91 years and found that aging was associated with an 
increase in pulse amplitude, steepening of the diastolic decay and a decrease in the 
pressure of the diastolic wave (Kelly et a!., 1989). Stiffening thus explains why 
diastolic pressures normally decrease and pulse pressure increases during aging. 
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2.3.2 Obesity 
Obesity has reached epidemic levels and carries a risk for cardiovascular disease. 
According to data from the National Health and Nutrition Examination Survey in US 
from 1988 to 1994, the prevalence of overweight (BMI > 25 kg/m2) was 11.3% among 
6 to 11 year olds, 1 0.5% among 12 to 19 year olds, and 55% among adults, whereas in 
1999 to 2000, corresponding prevalence rates had increased to 15 .3o/o, 15 .5%, and 
64.5%, respectively (Ogden et al., 2002). Excess weight has been shown to carry a 
risk for stroke, incident cardiovascular disease, cardiovascular mortality, and all-cause 
mortality among middle-aged and elderly participants in longitudinal study (Wilson et 
al., 2002). Excess body fat, abdominal visceral fat, and larger waist circumference 
have been identified as risk factors for accelerated arterial stiffening in elderly 
participants (Sutton Tyrell et al., 2001). 
In a study done by Wildman et a!. in 186 young adults and 177 older adults where 
aortic stiffness was measured by aortic pulse wave velocity found that higher body 
weight, body mass index, waist and hip circumferences, and waist-hip ratio were 
strongly correlated with higher pulse wave velocity, independent of age, systolic blood 
pressure, race, and sex (Wildman eta!., 2003). 
2.3.3 Gender 
In a group of elderly hypertensive patients matched for age, height and mean arterial 
pressure, there was no difference in systolic blood pressure between men and women, 
but diastolic blood pressure was lower and pulse pressure and the Agl higher in 
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women (Gatzka et a/., 2001 ). In the Atherosclerosis Risk in Communities study in a 
4 701 men and women found that arterial stiffness about twice as high in women as in 
men. In the Framingham Heart study, the incidence of ultrasonically diagnosed 
ventricular hypertrophy among subjects with glucose intolerance or diabetes was 
greater in women than in men (Lougun and Gosling, 1982). 
2.3.4 Heart rate 
Studies performed in rats have shown that when pacing increases heart rate, carotid 
and femoral arteries distensibilities are reduced (Mangoni et a/., 1996). In paced 
animal models, increased heart rate was shown to increase stiffness of large elastic 
arteries while having a variable effect on muscular arteries (Mangoni et a/., 1996). 
These suggest that heart rate might be one of the factors that modulates arterial 
mechanical properties and thus, potentially participates in their abnormality in several 
conditions and diseases. However, there is a little evidence exists whether heart rate 
plays a similar role in humans and the available data have given conflicting results. 
In a study reported by Lantelme et al., in 22 subjects with permanent cardiac pacing 
found that there was a highly significant effect of heart rate on PWV (Lantelme et a!., 
2002). The similar finding also reported by Giannattasio et al., in 20 outpatients who 
chronically implanted with a dual-chamber pacemaker because of sick sinus syndrome 
or an atrio-ventricular block, found that increases in heart rate markedly effect arterial 
distensibility (Giannattasio et al., 2003). However, Wilkinson et al., showed a 
negative relationship between augmentation index and heart rate (Wilkinson et al., 
2002) 
18 
2.3.5 Hyperglycaemia and hyperinsulinaemia. 
In the ARIC study, where they used ultrasound for measurements of carotid artery 
stiffness in a large population survey comprising of 4 701 white and black subjects 
found that 5% subjects had type 2 diabetes. In the entire study group, arterial stiffness 
increased with increasing concentrations of fasting glucose, independent of race or 
gender. In all non-diabetic patients, fasting serum insulin was associated with arterial 
stiffness, again even after adjustment for age, smoking and total cholestrol. This cross-
sectional study also found that hyperinsulinaemia and hyperglycaemia synergistically 
contributed to arterial stiffness, independent of artery wall thickness, in both men and 
women (Salooma eta!., 1995). 
In the Strong Heart study, 181 0 diabetic and 944 normal American Indians with a 
mean age of 60 years were studied using an ultrasound technique found that diabetic 
patients had significantly increased arterial stiffness even after adjustment for age, 
gender, height, BMI, systolic blood pressure and use of anti-hypertensive drugs 
(Devereux eta!., 2000). 
Type 1 diabetic patients have also been shown to have stiffer larger arteries in many 
studies. Giannattasio et a! measured arterial stiffness in the abdominal aorta and in 
radial and common carotid artery using an arterial wall echo-tracking technique in 133 
type 1 diabetic patients and in 70 age-matched control subjects and found that in the 
diabetic patients, regardless of the presence of complications, arterial stiffness was 
increased at all arterial sites when compared to control subjects (Giannattasio et a!., 
1999). 
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In the Hoorn population-based study of 619 individulas and assessed central artery 
stiffness by measuring total systemic arterial compliance, aortic pressure augmentation 
index and carotid-femoral transit rime found that after adjustment for sex, age, heart 
rate, height, body mass index and mean arterial pressure, type 2 diabetes was 
associated with decreased total systemic arterial compliance, increased aortic 
augmentation index, and decreased carotid-femoral transit time (Schram et al., 2004). 
2.3.6 Hypertension 
Blood pressure is a powerful cardiovascular risk factor that acts on the arterial wall 
and is responsible in part of various cardiovascular even such as cerebrovascular 
events and ischaemic heart disease. Arterial stiffness and wave reflections have been 
widely investigated in hypertensive subjects. One of this reason, because from 
epidemiological studies, systolic blood pressure is more informative as cardiovascular 
risk factor compared to diastolic blood pressure, particularly in patients older than 50 
years of age and it has been shown that pulse pressure is independent marker of 
cardiovascular risk, mainly for myocardial infarction (Safar, 2001 ). 
Increased arterial stiffness may increase cardiovascular morbidity and mortality 
because of an elevation of systolic blood pressure (SBP), which raised left ventricular 
after load, and because of decrease in diastolic blood pressure (DBP), which alters 
coronary perfusion (Safar, 1989). In a cohort study done by Laurent et al. in 1980 
essential hypertensive patients who attended the outpatient hypertensive clinic found 
that the aortic stiffness as measured as PWV is an independent predictor of all-cause 
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and cardiovascular mortality in patients with essential hypertension (Laurent et a!., 
1990). 
In a longitudinal study done by Demellis and Panaretou in 2512 subjects who assessed 
the predictive value of aortic stiffness on future hypertension in non-hypertensive 
subjects with BP< 140/90. In this study, aortic stiffness was determined by 
echocardiography at baseline and was follow up for 4 years. From this study, they 
found that there is stepwise increase in hypertension incidence and aortic stiffness 
significantly associated with the progression to future hypertension (Demellis and 
Panaretou, 2005). This findings are similar with the previous study by Liao et a!. , 
which has shown that lower arterial elasticity (high stiffness) in the common carotid 
artery is related to the development of hypertension (Liao et a!., 1999). This result 
shows that arterial stiffness may help in the evaluation of the individual risk in 
hypertensive patients regularly attending the outpatient clinic of a university hospital 
and helps to identify patients at high risk for hypertension. 
2.3. 7 Smoking 
Smoking is a major risk factor in the development and progression of cardiovascular 
disease. Smoking may have both short and long term effects on arterial stiffness. In a 
study which compared the acute and chronic effects of smoking on large-artery 
properties in 185 healthy young smokers and non-smokers before and for 15 minutes 
after smoking 1 cigarette (nicotine content, 1.2 mg) found that although brachial blood 
pressure was not different, the aortic systolic blood pressure and augmentation index 
were higher in chronic smokers than in non-smokers (Mahmud and Feely, 2003). 
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Levenson et al. studied the relationship between smoking and arterial stiffness in 33 
normotensive and 80 hypertensive subjects also found that in both groups, smokers 
had increased arterial stiffness (Levenson et al., 1987). 
In a group of 248 healthy subjects, all 50 years of age, stiffness of the common carotid 
artery was measured by using ultrasound and showed that smoking was independently 
associated with arterial stiffness (Jonason et al., 1997). The similar finding also 
shown in a study by Taniwaki et a/. , arterial stiffness was measured using aortic PWV 
measurements in 271 diabetic patients and 285 healthy subjects which demonstrated 
that smoking was independently associated with increased arterial stiffness (Taniwaki 
et al., 1999). 
2.3.8 Hypcrcholcstrolcmia 
Data regarding the association between lipid abnormalities and arterial stiffness are 
controversial. In a study of 62 normotensive and 201 uncomplicated hypertensive 
subjects with a wide range of total cholestrol concentrations found that arterial 
stiffness which was measured with ultrasound and by applanation tonometry was not 
correlated with serum cholestrol (Saba et al., 1999). 
In contrast with the study done by Dart et al. , who found that there is a significant 
relationship between serum cholestrol and arterial stiffness in 54 healthy subjects 
using the ultrasound technique (Dart et al. 1991) 
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Toikka et al., measured compliance of the aorta with MRI in 25 healthy subjects aged 
28 to 39 years old and in 10 age-matched subjects with familial hypercholestrolemia 
found that the aortic compliance was similar between the groups (Toikka et al., 1999) 
2.3.9 Anti-hypertensive drugs 
Different blood pressure lowering drugs have different effects on central aortic 
pressures. Short-term studies have shown that various classes of blood pressure-
lowering drugs may have profoundly different effects on pulse wave morphology 
despite similar effects on brachial artery pressures (Chen et al. 1995). 
In The CAFE study in 2073 participants for up to 4 years follow-up, who examined 
the impact of 2 different blood pressure (BP) lowering-regimens (atenolol-based 
regimen and amlodipine based regimen) on derived central aortic pressures, and the 
results shown that despite similar brachial systolic blood pressure between treatment 
groups, there were substantial reductions in central aortic pressures with the 
amlodipine regimen (Williams et al., 2006). 
A number of studies have compared the effects on arterial stiffness of ACE inhibitors 
and calcium channel blocker. In end stage renal failure (ESRF) treatment for 1 year 
with perindopril or nitrendipine similarly reduced BP and more effectively reduced 
carotid than brachial pressure. Both similarly reduced PWV and carotid AI, although 
only perindopril reduced left ventricular hypertrophy (London et al., 1994 ). There are 
conflicting data regarding the effects of diuretics on arterial wall stiffness. For 
example, despite reducing BP, neither indapamide or canrenoate changed PWV 
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(Laurent et a!., 1990). The felodipine more effectively improved brachial artery 
compliance than hydrochlorothiazide (Asmar eta!., 1993). 
2.4 Arterial stiffness as a predictor of vascular disease. 
In follow-up studies, pulse pressure has been shown to predict cardiovascular disease 
independent of mean arterial pressure (Domanski et a!., 1999). In the Framingham 
cohort study, pulse pressure was the best predictor in subjects over 60 years 
suggesting that age-related stiffening of arteries is an important risk factor for 
coronary heart disease (Franklin eta/., 2001). 
Recently, the association between stiffness and cardiovascular disease has also been 
studied using direct measures of arterial stiffness. In cross-sectional studies, PWV 
correlated with cardiovascular risk factors such as age, gender, systolic blood pressure, 
diabetes, heart rate, carotid plaques and intima-media thickness (Zureik eta!., 2002). 
The augmentation index derived from non-invasive radial artery tonometry predicts 
the presence and severity of coronary artery lesions independent of smoking, total and 
LDL cholestrol, age, hypertension and diabetes (Weber eta!., 2004). Both the AI and 
PWV predicted ischaemic thresholds in patients with coronary heart disease and the 
AI measured invasively from the ascending aorta with a fluid-filled system ts 
associated with angiographic changes in coronary arteries (Hayashi et a!., 2002). 
In over 3000 elderly subjects of the Rotterdam study, aortic stiffness measured by 
carotid artery distensibility and carotid-femoral PWV measured by ultrasonography 
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